Correlation Between Knight Therapeutics and Covalon Technologies

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Knight Therapeutics and Covalon Technologies at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Knight Therapeutics and Covalon Technologies into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Knight Therapeutics and Covalon Technologies, you can compare the effects of market volatilities on Knight Therapeutics and Covalon Technologies and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Knight Therapeutics with a short position of Covalon Technologies. Check out your portfolio center. Please also check ongoing floating volatility patterns of Knight Therapeutics and Covalon Technologies.

Diversification Opportunities for Knight Therapeutics and Covalon Technologies

-0.63
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Knight and Covalon is -0.63. Overlapping area represents the amount of risk that can be diversified away by holding Knight Therapeutics and Covalon Technologies in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Covalon Technologies and Knight Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Knight Therapeutics are associated (or correlated) with Covalon Technologies. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Covalon Technologies has no effect on the direction of Knight Therapeutics i.e., Knight Therapeutics and Covalon Technologies go up and down completely randomly.

Pair Corralation between Knight Therapeutics and Covalon Technologies

Assuming the 90 days trading horizon Knight Therapeutics is expected to under-perform the Covalon Technologies. But the stock apears to be less risky and, when comparing its historical volatility, Knight Therapeutics is 1.43 times less risky than Covalon Technologies. The stock trades about -0.1 of its potential returns per unit of risk. The Covalon Technologies is currently generating about 0.05 of returns per unit of risk over similar time horizon. If you would invest  336.00  in Covalon Technologies on August 28, 2024 and sell it today you would earn a total of  9.00  from holding Covalon Technologies or generate 2.68% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Knight Therapeutics  vs.  Covalon Technologies

 Performance 
       Timeline  
Knight Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Knight Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy fundamental indicators, Knight Therapeutics is not utilizing all of its potentials. The recent stock price disarray, may contribute to short-term losses for the investors.
Covalon Technologies 

Risk-Adjusted Performance

4 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Covalon Technologies are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unfluctuating basic indicators, Covalon Technologies may actually be approaching a critical reversion point that can send shares even higher in December 2024.

Knight Therapeutics and Covalon Technologies Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Knight Therapeutics and Covalon Technologies

The main advantage of trading using opposite Knight Therapeutics and Covalon Technologies positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Knight Therapeutics position performs unexpectedly, Covalon Technologies can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Covalon Technologies will offset losses from the drop in Covalon Technologies' long position.
The idea behind Knight Therapeutics and Covalon Technologies pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.

Other Complementary Tools

Transaction History
View history of all your transactions and understand their impact on performance
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk